Background illustration for clinical trials search

Paid Clinical Trials Augusta

Discover 194 paid clinical trials in Augusta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
Location: Augusta GA, Winston-Salem NC, Birmingham AL, Ocala FL,
Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 18+

Code: NCT06163430

Phase 1, Phase 2, Recruiting

VitD3 Supplementation in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Augusta GA
Sponsor: Amany Keruakous, MD, MS.

Sex: All

Age: 18+

Code: NCT05846880

Early Phase 1, Recruiting

A Study of Sovilnesib in Subjects With Ovarian Cancer

for
High Grade Serous Adenocarcinoma of Ovary,
Location: Atlanta GA, Birmingham AL, Buffalo NY, Oklahoma City OK
Sponsor: Volastra Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06084416

Phase 1, Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Augusta GA, Charleston SC, Charlotte NC, Atlanta GA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Augusta GA, Birmingham AL, Nashville TN, Orlando FL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

for
Acute Myeloid Leukemia (AML)
Location: Augusta GA, New York NY, Fairway KS, Houston TX,
Sponsor: Bio-Path Holdings, Inc.

Sex: All

Age: 18+

Code: NCT02781883

Phase 2, Recruiting

Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy

for
Cytokine Release Syndrome
Location: Augusta GA, Durham NC, Pittsburgh PA, Boston MA,
Sponsor: CytoAgents, Inc.

Sex: All

Age: 18+

Code: NCT05905328

Phase 1, Phase 2, Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: Augusta GA, Charlotte NC, Atlanta GA, Jacksonville FL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Augusta GA, Greenville SC, Charlotte NC, Atlanta GA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

for
Solid Tumor
Location: Augusta GA, Tampa FL, Chicago IL, New York NY,
Sponsor: Eisai Inc.

Sex: All

Age: 18+

Code: NCT04300556

Phase 1, Phase 2, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Augusta GA, Charlotte NC, Statesville NC,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for
Breast Cancer, Breast Cancer Metastatic,
Location: Augusta GA, Charlotte NC, Atlanta GA, Durham NC,
Sponsor: Incyclix Bio

Sex: All

Age: 18+

Code: NCT05735080

Phase 1, Phase 2, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Augusta GA, Atlanta GA, Fleming Island FL, Roanoke VA,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Phase 4, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Augusta GA, Atlanta GA, Durham NC, Birmingham AL,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase 2, Recruiting

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

for
AAA - Abdominal Aortic Aneurysm
Location: Augusta GA, Greenville SC, Atlanta GA, Decatur GA,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT06218875

Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

for
Neuroblastoma
Location: Augusta GA, Charleston SC, Charlotte NC, Durham NC,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT05489887

Phase 2, Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Augusta GA, Columbus OH, Cleveland OH, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase 1, Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Augusta GA, Charlottesville VA, Indianapolis IN,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT05646316

Phase 3, Recruiting

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

for
Multiple Myeloma, Autologous Stem Cell Transplantation
Location: Augusta GA
Sponsor: Augusta University

Sex: All

Age: 18+

Code: NCT06588413

Phase 3, Recruiting

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

for
Acute Respiratory Distress Syndrome, Infections
Location: Augusta GA, Louisville KY, Pittsburgh PA, Hershey PA,
Sponsor: BioAegis Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05947955

Phase 2, Recruiting